Skip to main navigation
Auris Medical : development of novel pharmaceutical therapies to prevent or treat severe inner ear disorders like tinnitus and hearing loss
  • Company
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Boards
    • Milestones
    • Collaborations
  • Pathologies
    • The Inner Ear
    • Tinnitus
    • Hearing loss
    • Vertigo
    • Antipsychotic side effects
  • Product Candidates
    • Pipeline
    • AM-125
    • AM-201
    • AM-301
    • Sonsuvi® (AM-111)
    • Keyzilen® (AM-101)
    • Intratympanic administration
  • Newsroom
    • News
    • Presentations
    • Publications
    • Links
  • Investors

      Investor Relations

      • Investor Relations
      • Events and Presentations
      • Corporate Governance
      • Financial Information
      • Press Releases
      • Stock Information
      • Major Shareholders
      • Investor FAQs
      • Investor Contact
      • Information Request
      • Email Alerts
      • Information related to Reverse Split

 

 

Breadcrumb

Home /  Investors /  Investor Contact / 

Investor Contact

Primary IR Contacts
Thomas Meyer
Chairman and CEO
Auris Medical Holding Ltd.
E-mail: Investors[at]aurismedical.com

Investors

    Investors

    • Investor Relations
    • Events and Presentations
    • Corporate Governance
    • Financial Information
    • Press Releases
    • Stock Information
    • Major Shareholders
    • Investor FAQs
    • Investor Contact
    • Information Request
    • Email Alerts
    • Information related to Reverse Split

Investor Toolkit

  • Print Page
  • RSS Feeds

Careers   |    Contacts

Copyright © Auris Medical 2021